Interleukin-1β targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis
- 26 September 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 337 (2) , 647-654
- https://doi.org/10.1016/j.bbrc.2005.09.107
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The Role of Cyclooxygenase 2 in Ulcerative Colitis-Associated NeoplasiaThe American Journal of Pathology, 2000
- The Pathogenesis of Mucosal Inflammation in Murine Models of Inflammatory Bowel Disease and Crohn DiseaseAnnals of Internal Medicine, 1998
- Experimental models of inflammatory bowel diseaseGastroenterology, 1995
- Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.Gut, 1995
- Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient miceGastroenterology, 1994
- Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's diseaseClinical and Experimental Immunology, 1993
- Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporinDigestive Diseases and Sciences, 1993
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 1991
- A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in miceGastroenterology, 1990
- In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.Gut, 1987